Artery stenosis is the abnormal narrowing of an artery, which reduces blood flow to the organ or tissue downstream. It can happen in almost any artery in the body, from the coronary arteries feeding the heart to the carotid arteries supplying the brain and the leg arteries that keep you mobile. The most common cause by far is atherosclerosis, the slow buildup of fatty, calcified plaque inside artery walls, but it is not the only one. How much trouble stenosis causes depends heavily on where it is, how severe the narrowing has become, and whether the body has had time to build detour routes around the blockage.
How Artery Stenosis Develops
The process usually starts with damage to the inner lining of an artery, called the endothelium. High blood pressure, smoking, high cholesterol, and high blood sugar all injure this delicate layer. Once the lining is activated, fats from the bloodstream begin slipping into the artery wall, triggering an inflammatory response. Immune cells rush in to clean up the accumulated fat, but over time they become overwhelmed and die, forming a growing core of lipid-rich debris. Fibrous tissue and calcium deposits pile on top, creating what is known as an atherosclerotic plaque.1PubMed Central. Pathophysiology of Atherosclerosis This cascade of lipid retention, oxidation, and chronic inflammation happens at predictable sites where blood flow is turbulent, such as artery branch points.2The American Journal of Medicine. The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment
Plaques do not all behave the same way. Some are stable, with a thick fibrous cap that narrows the artery gradually over years. Others are “vulnerable,” with a thin cap covering a soft, lipid-rich core. A vulnerable plaque can rupture suddenly, exposing its contents to the bloodstream. The body reacts by forming a blood clot on the spot, which can abruptly block the artery entirely, causing a heart attack or stroke. So stenosis carries two distinct threats: the slow squeeze of progressive narrowing and the sudden emergency of plaque rupture.
Causes Beyond Atherosclerosis
While atherosclerosis accounts for the vast majority of artery stenosis, a few other conditions can narrow arteries through entirely different mechanisms. Fibromuscular dysplasia, or FMD, is an under-recognized arterial disease that affects small and medium-sized arteries without involving the usual buildup of plaque or inflammation.3CJC Open. Fibromuscular Dysplasia: A Focused Review for the Cardiologist It most commonly shows up in middle-aged women, though it can appear at any age, and it tends to affect the renal arteries (leading to high blood pressure) and the carotid arteries (risking stroke). Research has identified a genetic component involving a variant in the PHACTR1 gene, confirming that FMD is at least partly inherited.4PubMed. Fibromuscular Dysplasia: Contemporary Concepts and Future Directions
Other less common causes include vasculitis (inflammation of the blood vessel wall from autoimmune disease), radiation therapy to the chest or neck, and external compression from tumors or anatomic structures. In younger patients without traditional risk factors, these rarer causes deserve investigation rather than assuming the narrowing is from atherosclerosis.
When Narrowing Becomes Critical
An artery can lose a surprising amount of its internal diameter before symptoms appear. The relationship between the degree of narrowing and the actual drop in blood flow is not linear. Blood can squeeze through a moderately narrowed artery without much trouble at rest. The physics change dramatically once the stenosis reaches roughly 65 to 80 percent of the artery’s diameter. In that range, the energy lost as blood pushes through the bottleneck climbs steeply.5medRxiv. Critical Arterial Stenosis Revisited For the renal artery, for example, the critical threshold has been estimated at around 74 percent narrowing.
Demand matters too. A coronary artery stenosis that causes no problems at rest may become insufficient during exercise, when the heart needs more blood. The pressure drop across the narrowed segment is proportional to the square of the flow rate through it, so conditions that increase blood flow, such as physical exertion or anemia, amplify the mismatch between supply and demand.6PubMed. Dynamic mechanisms in human coronary stenosis This is why angina, the chest pain of coronary artery disease, classically strikes during exertion and eases with rest.
Symptoms Depend on Location
Stenosis is not a single disease with a single set of symptoms. Where the narrowing sits determines what goes wrong.
- Coronary arteries: Stenosis here starves the heart muscle of oxygen. The hallmark symptom is angina, a pressure-like chest pain or tightness that may radiate to the jaw, shoulder, or arm. It typically flares with exertion or stress and fades with rest. If a plaque ruptures and a clot forms, the result is a heart attack.
- Carotid arteries: These supply the brain. Many people with carotid stenosis have no symptoms at all until a stroke or a transient ischemic attack (a “mini-stroke” with temporary weakness, vision loss, or slurred speech). Among patients with 50 percent or greater carotid stenosis who had already experienced a minor ischemic event, the risk of recurrent stroke was roughly two and a half times higher than in those without significant narrowing.7PubMed Central. Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial
- Leg arteries: Peripheral artery disease (PAD) causes intermittent claudication, a cramping leg pain that appears during walking and eases when you stop. About a third of PAD patients experience this symptom. Research shows that gait is impaired from the very first steps, even before pain sets in, and worsens as the claudication builds.8PubMed Central. A biomechanical perspective on walking in patients with peripheral artery disease
- Renal arteries: Narrowing here can drive blood pressure up, sometimes to levels that resist multiple medications. The kidneys sense low blood flow and respond by activating hormonal systems that raise blood pressure throughout the body.
Asymptomatic Stenosis and the Silent Threat
One of the trickiest aspects of artery stenosis is that it can be severe yet produce no noticeable symptoms. Carotid stenosis is the clearest example. In a long-term follow-up study, patients with 50 to 99 percent carotid narrowing who had never experienced a stroke or TIA still faced a 10-year risk of stroke on the affected side of about 9 percent, rising to roughly 17 percent at 15 years.9JAMA Neurology. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis Those numbers may sound modest, but strokes are devastating events, and the risk is compounded by factors like smoking history, rising blood pressure, and impaired kidney function.10PubMed. Asymptomatic carotid artery stenosis: a summary of current state of evidence for revascularization and emerging high-risk features
The silence of the condition is partly because the body adapts. As arteries slowly narrow over months and years, the body can grow small detour vessels, known as collateral arteries, to reroute blood around the blockage. In the heart, collateral vessels interconnect the coronary arteries and provide an alternative blood supply when the primary route is partially or fully obstructed.11PubMed Central. The collateral circulation of the heart Exercise appears to encourage this process: increased blood flow through existing small channels raises shear forces on their walls, which stimulates them to enlarge, a process called arteriogenesis.12PubMed Central. Exercise Training as a Mediator for Enhancing Coronary Collateral Circulation: A Review of the Evidence Collateral development explains why some patients tolerate even total artery occlusion without a catastrophic event, while others have a heart attack from a much less severe blockage that progresses too quickly for collaterals to keep up.
How Stenosis Is Diagnosed
Doctors choose imaging and functional tests based on where the suspected narrowing is and how urgently they need information.
Ultrasound, often called duplex ultrasound, is the standard first-line screening tool for carotid and peripheral artery stenosis. It is painless, widely available, and involves no radiation. Its limitation is sensitivity: for vertebral artery stenosis of 50 percent or more, ultrasound detected the narrowing in about two-thirds of cases, compared with roughly 80 to 90 percent for contrast-enhanced MR angiography.13PubMed. Noninvasive detection of vertebral artery stenosis: a comparison of contrast-enhanced MR angiography, CT angiography, and ultrasound CT angiography also performed well, with excellent specificity in the same comparison. For the internal carotid artery specifically, newer photon-counting CT angiography has shown high accuracy at detecting clinically significant stenosis of 70 percent or greater.14European Journal of Radiology. Assessing internal carotid artery stenosis: Diagnostic Value of photon-counting detector CT angiography compared to Doppler ultrasound
For coronary arteries, catheter-based angiography remains the gold standard, but an image alone does not always answer whether a narrowing is actually restricting blood flow. That question is resolved by fractional flow reserve, or FFR, which measures the pressure difference across a stenosis during peak blood flow. In a landmark study, an FFR value below 0.75 identified reversible ischemia with 88 percent sensitivity, 100 percent specificity, and 93 percent overall accuracy.15PubMed. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses Current guidelines use a threshold of 0.80: patients below that cutoff benefit from having the blockage physically opened, while those above it generally do just as well with medications alone.16PubMed Central. Fractional Flow Reserve Assessment of Coronary Artery Stenosis
Medical Treatment
Before any talk of procedures, the first-line treatment for artery stenosis caused by atherosclerosis is aggressive medical therapy. The two pillars are cholesterol-lowering drugs and antiplatelet medications.
Statins do more than lower LDL cholesterol. In patients treated with simvastatin, plaque volume in the aorta decreased measurably within six months, and the degree of plaque shrinkage tracked closely with the reduction in LDL cholesterol.17PubMed. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy Separate research using intravascular ultrasound confirmed that intensive statin therapy promotes arterial wall remodeling, likely through anti-inflammatory effects that go beyond just clearing cholesterol from the blood.18PubMed. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial Plaques treated with statins tend to become smaller, denser, and less likely to rupture.
Antiplatelet drugs like aspirin reduce the risk of clots forming on rough plaque surfaces. For patients with symptomatic stenosis, particularly in the carotid or intracranial arteries, adding a second antiplatelet agent can provide additional protection. A randomized trial found that dual therapy with clopidogrel and aspirin reduced microembolic signals, tiny clot fragments detectable by transcranial ultrasound, by about 42 percent compared with aspirin alone in patients with large artery stenosis.19The Lancet Neurology. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic large artery stenosis (CLAIR) Dual antiplatelet therapy has become the standard around the time of carotid stenting procedures as well.20PubMed Central. Antiplatelet therapy for carotid artery stenting The duration of dual therapy must be balanced against bleeding risk, which is why these decisions are individualized.
Procedures to Open Narrowed Arteries
When medications are not enough, interventional cardiologists and vascular surgeons have several ways to physically restore blood flow.
Balloon angioplasty threads a deflated balloon to the site of narrowing and inflates it to compress the plaque against the artery wall. A stent, a small wire mesh tube, is typically placed at the same time to hold the artery open. The main drawback is in-stent restenosis, where the artery gradually narrows again inside the stent, usually driven by an overgrowth of tissue on the inner surface rather than new atherosclerosis.21Cochrane Database of Systematic Reviews. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for in-stent restenosis of the femoropopliteal arteries In one long-term study, about a quarter of patients who had repeat angioplasty for in-stent restenosis needed another procedure on the same vessel within two years.22PubMed. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty Drug-eluting stents and drug-coated balloons were developed specifically to combat this problem by delivering anti-growth chemicals directly to the artery wall.
For the carotid arteries, endarterectomy, a surgical operation that physically removes the plaque from inside the artery, has been the standard treatment for decades. Carotid bypass, which reroutes blood around the stenosis using a grafted vessel, is an alternative when the anatomy favors it. In a matched comparison, both approaches showed similar long-term survival and stroke-free survival rates, though restenosis occurred somewhat less often after bypass.23PubMed. Carotid artery bypass versus endarterectomy as an alternative treatment of carotid artery stenosis: A propensity score matching analysis The choice between endarterectomy, stenting, and bypass depends on the patient’s anatomy, surgical risk, and the characteristics of the plaque itself.
A persistent clinical question is whether to fix carotid stenosis found incidentally in someone about to undergo heart bypass surgery. A randomized trial found that adding endarterectomy to planned coronary bypass did not significantly reduce stroke or death at five years compared with coronary bypass alone.24PubMed. Five-Year Results of Coronary Artery Bypass Grafting With or Without Carotid Endarterectomy in Patients With Asymptomatic Carotid Artery Stenosis: CABACS RCT Nonfatal stroke rates were actually numerically higher in the combined surgery group, though the difference was not statistically significant. Findings like these underscore the principle that not every narrowed artery needs a procedure, even when it looks severe on a scan.
Exercise and Plaque Regression
Structured exercise does more than improve fitness. A scoping review of controlled trials found that cardiac rehabilitation programs combining high-intensity interval training, aerobic exercise, and resistance training, alongside standard medical therapy, significantly reduced plaque volume as measured by intravascular ultrasound and carotid ultrasound. These programs also improved inflammatory markers and the ability of artery linings to relax and dilate properly.25PLOS ONE. Exercise-based cardiac rehabilitation and atherosclerotic plaque regression in ASCVD: Is exercise really a game-changer? A scoping review of controlled trials The evidence so far comes from relatively small trials involving a couple hundred participants in total, so the magnitude of the effect is still being defined. But the direction is consistent: exercise added to medication shrinks plaques more than medication alone.
For peripheral artery disease specifically, supervised walking programs are a cornerstone of treatment. They increase the distance patients can walk before claudication pain sets in, partly by improving the efficiency of muscles that are operating on a limited blood supply and partly by encouraging collateral vessel growth. Even in the absence of any measurable change in artery diameter, functional capacity can improve substantially.
Genetic Risk Factors You Cannot Control
Some people develop aggressive atherosclerosis despite textbook-perfect lifestyle habits. One emerging explanation involves lipoprotein(a), often written as Lp(a), a particle that resembles LDL cholesterol but carries an additional protein that promotes both plaque formation and clotting. The American Heart Association has recognized elevated Lp(a) as an independent, genetically determined, and causal risk factor for atherosclerotic cardiovascular disease. Roughly 70 to over 90 percent of the variation in Lp(a) levels between people is determined by their genes, and elevated Lp(a) continues to drive risk even in patients who have brought their standard LDL cholesterol down to target levels.26PubMed Central. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
The European Atherosclerosis Society has echoed this position, noting that extensive genetic evidence from Mendelian randomization studies supports a causal link between elevated Lp(a) and both atherosclerotic cardiovascular disease and aortic valve stenosis. People who carry rare loss-of-function variants that dramatically lower their Lp(a) are protected against cardiovascular events.27European Heart Journal. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement Unlike LDL cholesterol, Lp(a) does not respond meaningfully to statins or lifestyle changes. Several drugs specifically targeting Lp(a) are in late-stage clinical trials, and if they prove effective, they could open up a new treatment avenue for a risk factor that has until now been essentially untreatable.
Artificial Intelligence in Stenosis Detection
Reading CT angiography images for stenosis is time-consuming and somewhat subjective, with different radiologists sometimes grading the same narrowing differently. Machine learning algorithms are being trained to assist. A systematic review of these AI tools found a broad trend of high sensitivity and specificity, though performance varied depending on the vascular territory and the level of anatomic detail being assessed.28Neural Computing and Applications. Machine learning applications for vascular stenosis detection in computed tomography angiography: a systematic review and meta-analysis
In a head-to-head comparison, an AI-aided model for grading coronary stenosis outperformed both manual CT measurements and visual assessment of invasive angiograms at detecting 50 percent and 70 percent narrowings, across patient-level, vessel-level, and segment-level analyses. The only scenario where the AI did not reach statistical superiority was at the segment level compared with senior radiologists using the 70 percent threshold, where the two were essentially tied.29PubMed Central. Coronary stenosis assessment: AI-based CT quantification, visual analysis of invasive angiography, and quantitative coronary angiography The practical promise is not to replace cardiologists but to flag borderline cases more reliably and reduce the variability that comes with human reading, especially in busy clinical settings where scans pile up faster than specialists can review them.